Strategies for Optimizing Adherence in Patients with Schizophrenia

Title:

Strategies for Optimizing Adherence in Patients with Schizophrenia

Topic: Psychiatry
Relevant Terms: Adherence, Long-Acting Injectable, Motivational Interviewing, Schizophrenia, Self-Determination Theory
Primary Audience: Advanced Practice Registered Nurses, Psychiatric Registered Nurses, Registered Nurses
Launch Date: 14-Jan-14
Credits: 1 ANCC contact hour
Expiration Date: 14-Jan-15
Curriculum Name: Recovery in Schizophrenia

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Integrate evidence-based interventions for improved schizophrenia treatment adherence and compliance into daily practice
  2. Discuss efficacy, safety and PK data for long-acting injectable antipsychotics (LAI) for schizophrenia
  3. Select eligible patients for LAI intervention, and begin the dialog regarding LAI use
  4. Provide appropriate care and counsel for patients and their families

    Faculty

    Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN
    Associate Professor
    Specialty Coordinator, Psychiatric-Mental Health Nursing

    Yale University School of Nursing
    New Haven, CT
    Joyce M. Shea, DNSc, APRN, PMHCNS-BC
    Associate Professor and Elizabeth DeCamp McInerney Professor of Health Sciences
    Fairfield University School of Nursing
    Fairfield, CT
    Peter J. Weiden, MD
    Professor of Psychiatry
    University of Illinois Medical Center
    Chicago, IL
    DISCLOSURE OF CONFLICTS OF INTEREST
    Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CNE activity:
     
    • Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN, has no affiliations with commercial interests to disclose.
    • Joyce M. Shea, DNSc, APRN, PMHCNS-BC, has no affiliations with commercial interests to disclose.
    • Peter J. Weiden, MD, has affiliations with Delpor, Johnson & Johnson (Janssen), Lundbeck, Otsuka USA, Merck, Novartis, Sunovion, Genentech/Roche (Consultant); Johnson & Johnson (Janssen), Merck, Novartis, Sunovion (Speakers' Bureau); Genentech/Roche, Johnson & Johnson (Janssen), NIMH, Novartis, Sunovion, Neurocrine (Grant Support); and Delpor (Stockholder).
    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

    RMEI, LLC
    • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
    • Cynthia M. Kunzer, CMP, has no affiliations with commercial interests to disclose.
    • The patient in this activity has no affiliations with commercial interests to disclose.

    Postgraduate Institute for Medicine
    • Jan Hixon, RN, BSN, MA, has no affiliations with commercial interests to disclose.
    • Trace Hutchison, PharmD, has no affiliations with commercial interests to disclose.
    • Samantha Mattiucci, PharmD, has no affiliations with commercial interests to disclose.
    • Jan Schultz, RN, MSN, CCMEP, has no affiliations with commercial interests to disclose.
    DISCLOSURE OF UNLABELED USE
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

    CREDIT DESIGNATION
    This educational activity for 1.0 contact hours is provided by Postgraduate Institute for Medicine.

    ACCREDITATION STATEMENT
    Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    TARGET AUDIENCE
    This activity has been designed to meet the educational needs of registered nurses involved in the care of patients with schizophrenia.

    Estimated time to complete:  60 minutes
    Medium: Internet

    FEE INFORMATION
    There is no fee for this educational activity.

    COMMERCIAL SUPPORT
    This activity is jointly sponsored by RMEI, LLC and Postgraduate Institute for Medicine. RMEI gratefully acknowledges an educational grant from Otsuka America Pharmaceutical, Inc. in support of this CNE activity.

    HOW TO RECEIVE CREDIT
    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 ANCC Category 1 Credit(s)™. A statement of credit will be available to print from your user history page.
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Nurses who successfully complete the post-test and evaluation will receive CNE credit. You must score with a 70% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
       
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 5.0+ for Mac OSX 10.5 and above

    For video playback, install the latest version of Flash or Quicktime.
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above